New chemo strategy aims to stop deadly cancer spread
NCT ID NCT03110926
Summary
This study is testing whether adding a specific chemotherapy regimen (mFOLFOX6) before the usual treatment can help stop esophageal cancer from spreading to other parts of the body. It involves 40 adults with locally advanced but potentially removable esophageal cancer. The goal is to see if this extra step before standard chemo, radiation, and surgery improves survival by preventing the cancer from coming back elsewhere.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESOPHAGEAL CARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Rochester
Rochester, New York, 14642, United States
Conditions
Explore the condition pages connected to this study.